Evidence map›Paper›PMID 28912270›Full record

ArticleThe Journal of biological chemistry2017

The periplasmic transaminase PtaA of

Michael T Ringel, Gerald Dräger, Thomas Brüser

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. The biosynthesis of pyoverdines.Microbial cell (Graz, Austria) · 2018
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Michael T RingelFrom the Institute of Microbiology, Leibniz Universität Hannover, Herrenhäuser Strasse 2, 30419 Hannover, Germany and.
Gerald Drägerthe Institute of Organic Chemistry, Leibniz Universität Hannover, Schneiderberg 1 B, 30167 Hannover, Germany.
Thomas BrüserFrom the Institute of Microbiology, Leibniz Universität Hannover, Herrenhäuser Strasse 2, 30419 Hannover, Germany and brueser@ifmb.uni-hannover.de.
Leibniz University Hannover · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The periplasmic conversion of ferribactin to pyoverdine is essential for siderophore biogenesis in fluorescent pseudomonads, such as pathogenic

Indexed as

Amino Acid SequenceAmino Acid SubstitutionBacterial ProteinsBinding SitesCoenzymesComputational BiologyConserved SequenceDimerizationExpert SystemsGene DeletionGlutamic AcidKetoglutaric AcidsOligopeptidesPeptides, CyclicPeriplasmic ProteinsPoint MutationBacterial ProteinsCoenzymesdesferriferribactinferribactinGlutamic AcidKetoglutaric AcidsOligopeptidesPeptides, CyclicPeriplasmic ProteinspyoverdinPyridoxal PhosphateRecombinant ProteinsTransaminasesenzymeironperiplasmic tailoringPseudomonaspyoverdinespyridoxal phosphatesiderophoretransaminase

Identifiers

PMID28912270
PMCPMC5682972
OpenAlexW2755438204

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.